Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival

Malignant melanoma is a highly aggressive tumor causing most skin cancer-related deaths. Understanding the fundamental mechanisms responsible for melanoma progression and therapeutic evasion is still an unmet need for melanoma patients. Progression of skin melanoma and its dissemination to local or...

Full description

Bibliographic Details
Main Authors: Alberto Vázquez-Naharro, José Bustos-Tauler, Alfredo Floristán, Lourdes Yuste, Sara S. Oltra, Antònia Vinyals, Gema Moreno-Bueno, Àngels Fabra, Francisco Portillo, Amparo Cano, Patricia G. Santamaría
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/5/1200
_version_ 1797475475999686656
author Alberto Vázquez-Naharro
José Bustos-Tauler
Alfredo Floristán
Lourdes Yuste
Sara S. Oltra
Antònia Vinyals
Gema Moreno-Bueno
Àngels Fabra
Francisco Portillo
Amparo Cano
Patricia G. Santamaría
author_facet Alberto Vázquez-Naharro
José Bustos-Tauler
Alfredo Floristán
Lourdes Yuste
Sara S. Oltra
Antònia Vinyals
Gema Moreno-Bueno
Àngels Fabra
Francisco Portillo
Amparo Cano
Patricia G. Santamaría
author_sort Alberto Vázquez-Naharro
collection DOAJ
description Malignant melanoma is a highly aggressive tumor causing most skin cancer-related deaths. Understanding the fundamental mechanisms responsible for melanoma progression and therapeutic evasion is still an unmet need for melanoma patients. Progression of skin melanoma and its dissemination to local or distant organs relies on phenotypic plasticity of melanoma cells, orchestrated by EMT-TFs and microphthalmia-associated TF (MITF). Recently, melanoma phenotypic switching has been proposed to uphold context-dependent intermediate cell states benefitting malignancy. LOXL3 (lysyl oxidase-like 3) promotes EMT and has a key role in human melanoma cell survival and maintenance of genomic integrity. To further understand the role of Loxl3 in melanoma, we generated a conditional Loxl3-knockout (KO) melanoma mouse model in the context of BrafV600E-activating mutation and Pten loss. Melanocyte-Loxl3 deletion increased melanoma latency, decreased tumor growth, and reduced lymph node metastatic dissemination. Complementary in vitro and in vivo studies in mouse melanoma cells confirmed Loxl3’s contribution to melanoma progression and metastasis, in part by modulating phenotypic switching through Snail1 and Prrx1 EMT-TFs. Importantly, a novel LOXL3-SNAIL1-PRRX1 axis was identified in human melanoma, plausibly relevant to melanoma cellular plasticity. These data reinforced the value of LOXL3 as a therapeutic target in melanoma.
first_indexed 2024-03-09T20:45:38Z
format Article
id doaj.art-617f56d8f483488cba6fc09240bebe19
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T20:45:38Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-617f56d8f483488cba6fc09240bebe192023-11-23T22:47:24ZengMDPI AGCancers2072-66942022-02-01145120010.3390/cancers14051200Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and SurvivalAlberto Vázquez-Naharro0José Bustos-Tauler1Alfredo Floristán2Lourdes Yuste3Sara S. Oltra4Antònia Vinyals5Gema Moreno-Bueno6Àngels Fabra7Francisco Portillo8Amparo Cano9Patricia G. Santamaría10Departamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, SpainDepartamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, SpainDepartamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, SpainDepartamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, SpainDepartamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, SpainOncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, SpainDepartamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, SpainOncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, SpainDepartamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, SpainDepartamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, SpainDepartamento de Bioquímica UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, SpainMalignant melanoma is a highly aggressive tumor causing most skin cancer-related deaths. Understanding the fundamental mechanisms responsible for melanoma progression and therapeutic evasion is still an unmet need for melanoma patients. Progression of skin melanoma and its dissemination to local or distant organs relies on phenotypic plasticity of melanoma cells, orchestrated by EMT-TFs and microphthalmia-associated TF (MITF). Recently, melanoma phenotypic switching has been proposed to uphold context-dependent intermediate cell states benefitting malignancy. LOXL3 (lysyl oxidase-like 3) promotes EMT and has a key role in human melanoma cell survival and maintenance of genomic integrity. To further understand the role of Loxl3 in melanoma, we generated a conditional Loxl3-knockout (KO) melanoma mouse model in the context of BrafV600E-activating mutation and Pten loss. Melanocyte-Loxl3 deletion increased melanoma latency, decreased tumor growth, and reduced lymph node metastatic dissemination. Complementary in vitro and in vivo studies in mouse melanoma cells confirmed Loxl3’s contribution to melanoma progression and metastasis, in part by modulating phenotypic switching through Snail1 and Prrx1 EMT-TFs. Importantly, a novel LOXL3-SNAIL1-PRRX1 axis was identified in human melanoma, plausibly relevant to melanoma cellular plasticity. These data reinforced the value of LOXL3 as a therapeutic target in melanoma.https://www.mdpi.com/2072-6694/14/5/1200LOXL3melanomamelanoma metastasisgenetic mouse modelEMTcellular plasticity
spellingShingle Alberto Vázquez-Naharro
José Bustos-Tauler
Alfredo Floristán
Lourdes Yuste
Sara S. Oltra
Antònia Vinyals
Gema Moreno-Bueno
Àngels Fabra
Francisco Portillo
Amparo Cano
Patricia G. Santamaría
Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
Cancers
LOXL3
melanoma
melanoma metastasis
genetic mouse model
EMT
cellular plasticity
title Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
title_full Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
title_fullStr Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
title_full_unstemmed Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
title_short Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
title_sort loxl3 promotes melanoma progression and dissemination influencing cell plasticity and survival
topic LOXL3
melanoma
melanoma metastasis
genetic mouse model
EMT
cellular plasticity
url https://www.mdpi.com/2072-6694/14/5/1200
work_keys_str_mv AT albertovazqueznaharro loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT josebustostauler loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT alfredofloristan loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT lourdesyuste loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT sarasoltra loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT antoniavinyals loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT gemamorenobueno loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT angelsfabra loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT franciscoportillo loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT amparocano loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival
AT patriciagsantamaria loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival